相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion
Shou-Hua Wang et al.
TUMOR BIOLOGY (2016)
HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas
Yu Zhu et al.
ONCOTARGET (2016)
Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway
Hongxue Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A. Masters et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Gabriel Eades et al.
MOLECULAR CANCER RESEARCH (2015)
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
Jing Liu et al.
PLOS ONE (2015)
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis (vol 16, 139, 2015)
Jiayan Fan et al.
GENOME BIOLOGY (2015)
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Reck et al.
ANNALS OF ONCOLOGY (2014)
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis
Xiaodong Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line
Ke Zhang et al.
MOLECULAR MEDICINE REPORTS (2014)
Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes
Jingcheng Yang et al.
LUNG CANCER (2014)
Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes
Senthilvelan Manohar et al.
NEUROTOXICITY RESEARCH (2014)
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
P. Hou et al.
CELL DEATH & DISEASE (2014)
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
Ali Zhang et al.
CELL RESEARCH (2013)
Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal
Yue Wang et al.
DEVELOPMENTAL CELL (2013)
Long Non-Coding RNA in Cancer
Nina Hauptman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
Madhu S. Kumar et al.
CELL (2012)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan et al.
CELL (2012)
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R. Kratz et al.
LANCET (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1
Tian Hu Wang et al.
ONCOLOGY REPORTS (2012)
The hallmarks of cancer A long non-coding RNA point of view
Tony Gutschner et al.
RNA BIOLOGY (2012)
No-Nonsense Functions for Long Noncoding RNAs
Takashi Nagano et al.
CELL (2011)
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth
Lars Henning Schmidt et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
The Emergence of lncRNAs in Cancer Biology
John R. Prensner et al.
CANCER DISCOVERY (2011)
Transcribed dark matter: meaning or myth?
Chris P. Ponting et al.
HUMAN MOLECULAR GENETICS (2010)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Small cell lung cancer
Taimur Sher et al.
MAYO CLINIC PROCEEDINGS (2008)
Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts
Satoshi Anai et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells
Jing Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2006)